首页> 外文会议>International symposium on controlled release of bioactive materials;Consumer diversified products conference >PHARMACOKINETIC STUDY OF ~(14)C-VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) MICROSPHERES IN RATS
【24h】

PHARMACOKINETIC STUDY OF ~(14)C-VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) MICROSPHERES IN RATS

机译:大鼠〜(14)C血管内皮生长因子(VEGF)微球的药代动力学研究

获取原文

摘要

Poly(lactic-co-glycolic) acid microspheres are utilized to alter the pharmacokinetics of Vascular Endothelial Growth Factor (VEGF) following s.c. administration. The PK parameters of VEGF in PLGA microspheres were compared with those of ~(14)C-VEGF solutions, using a rat model. The s.c. administration of protein solutions resulted in high plasma and low s.c. concentrations, suggesting rapid absorption and elimination. Whereas, s.c. administration of the microsphere formulations resulted in low plasma and high s.c. site concentrations, suggesting that the absorption phase is controlled by release rate from the microspheres. The in vitro and in vivo release and microsphere degradation rates followed the same rank order and confirmed that drug release was diffusion controlled.
机译:聚(乳酸-乙醇酸)微球被用来在s.c.之后改变血管内皮生长因子(VEGF)的药代动力学。管理。使用大鼠模型,将PLGA微球中VEGF的PK参数与〜(14)C-VEGF溶液的PK参数进行比较。 s.c.蛋白质溶液的给药导致高血浆和低s.c.浓度高,提示快速吸收和消除。而s.c.微球制剂的给药导致低血浆和高s.c。位点浓度,表明吸收相受微球的释放速率控制。体外和体内释放以及微球降解速率遵循相同的等级顺序,并证实药物释放是受扩散控制的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号